NSE · SUNPHARMA.NS
Sun Pharmaceutical Industries Limited
₹1,825.50+₹64.50 (+3.66%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the upper half of its reported 52-week range, 10.82% below the high.
Loading market information…
NSE · WINDLAS.NS · INR
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 09:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Windlas Biotech Limited’s quoted price sits in the lower half of its reported 52-week range, 25.11% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Windlas Biotech Limited’s forward annual dividend is ₹6.30 per share, paid annual. The forward yield is 0.71% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Windlas Biotech Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Windlas Biotech Limited functions as a comprehensive contract development and manufacturing organization (CDMO). Its CDMO offerings span the full product lifecycle, encompassing initial discovery, subsequent development, licensing, and large-scale commercial production of various generic pharmaceutical and nutraceutical items. Through these services, it assists clients in bringing both established and innovative pharmaceutical and nutraceutical products to market, which are then sold under the clients' proprietary brand names. Beyond its CDMO segment, Windlas Biotech also develops and manufactures its own portfolio of domestic trade generics and over-the-counter (OTC) brands, catering to the nutritional, ayurvedic, wellness, and personal care sectors. These in-house products reach consumers via a dual distribution approach: traditional offline channels like distributors, stockists, retail pharmacies, and institutional tenders, alongside a robust online presence through various e-commerce platforms. The company's international reach extends through exports, primarily to markets such as Vietnam, Myanmar, Sri Lanka, Thailand, the Philippines, Cambodia, Fiji, Trinidad & Tobago, and South Africa. Established in 2001, Windlas Biotech is headquartered in Gurugram, India.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 09:01 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹1,825.50+₹64.50 (+3.66%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the upper half of its reported 52-week range, 10.82% below the high.
₹9,836.50+₹172.50 (+1.78%)
Divi's Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 0.11% below the high.
₹886.00-₹35.10 (-3.81%)
Sigma Advanced Systems Limited’s quoted price sits in the upper half of its reported 52-week range, 23.95% below the high.
₹646.90-₹34.00 (-4.99%)
Bliss GVS Pharma Limited’s quoted price sits in the upper half of its reported 52-week range, 12.57% below the high.
₹1,738.70-₹74.10 (-4.09%)
Evonile Pharma Limited’s quoted price sits in the upper half of its reported 52-week range, 32.84% below the high.
₹19.46-₹0.95 (-4.65%)
Syncom Formulations (India) Limited’s quoted price sits in the upper half of its reported 52-week range, 29.21% below the high.
₹500.90+₹7.70 (+1.56%)
Amrutanjan Health Care Limited’s quoted price sits in the lower half of its reported 52-week range, 33.57% below the high.
₹306.25-₹6.60 (-2.11%)
Bajaj Healthcare Ltd’s quoted price sits in the lower half of its reported 52-week range, 37.36% below the high.
